1. Corporate Officers - B
2. Bell Graeme

Insider Trading History of Bell Graeme

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Bell Graeme since 2016. The trader's CIK number is 1643757. At the time of the last reporting, Bell Graeme was the Executive VP and CFO of Intellia Therapeutics, Inc.. (stock ticker symbol NTLA). Also see all insider trading activities at Intellia Therapeutics, Inc..

Note that in the past Bell Graeme also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Intellia Therapeutics, Inc. (NTLA) by Bell Graeme

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2018	NTLA	0	$0	0	$0	8,000	$107,840

Yearly summary of insider trading at Anacor Pharmaceuticals Inc (ANAC) by Bell Graeme

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	ANAC	0	$0	751	$74,559	0	$0

Insider trading activities at 2 companies by Bell Graeme:

1. Intellia Therapeutics, Inc. (NTLA)

2. Anacor Pharmaceuticals Inc (ANAC)

Table 1. Insider trading of Intellia Therapeutics, Inc. (NTLA) by Bell Graeme

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2018-03-28	NTLA	Option Ex	8,000	13.48	107,840

Table 2. Insider trading of Anacor Pharmaceuticals Inc (ANAC) by Bell Graeme

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-06-01	ANAC	Sale	751	99.28	74,559

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bell Graeme (Executive VP and CFO of Intellia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month